ask="N/A"
ask_size="N/A"
average_daily_volume="50997"
bid="N/A"
bid_size="N/A"
book_value="0.43"
change="-0.04"
change_from_200_day_moving_average="0.02"
change_from_50_day_moving_average="0.06"
change_from_52_week_high="-1.23"
change_From_52_week_low="0.48"
change_in_percent="-1.67%"
close="2.36"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.34"
ebitda="-8.28M"
eps_estimate_current_year="-0.31"
eps_estimate_next_quarter="-0.06"
eps_estimate_next_year="-0.33"
ex_dividend_date="N/A"
float_shares="12390000"
high="2.42"
high_52_weeks="3.59"
last_trade_date="1/13/2017"
last_trade_price="2.36"
last_trade_size="100"
last_trade_time="4:02pm"
low="2.35"
low_52_weeks="1.88"
market_capitalization="31.57M"
moving_average_200_day="2.34"
moving_average_50_day="2.30"
name="Can-Fite Biopharma Ltd Sponsore"
notes="N/A"
one_year_target_price="5.00"
open="2.42"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+0.91%"
percent_change_from_50_day_moving_average="+2.48%"
percent_change_from_52_week_high="-34.26%"
percent_change_from_52_week_low="+25.53%"
previous_close="2.40"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.61"
price_per_sales="165.59"
revenue="193916.00"
shares_outstanding="13379000"
short_ratio="8.62"
stock_exchange="ASE"
symbol="CANF"
volume="24524"
weeks_range_52="1.88 - 3.59"
